Skip to main content

ZURICH HEART HOUSE

The Zurich Heart House creates and communicates new knowledge in the field of cardiovascular diseases and supports through its affiliation with the Center for Molecular Cardiology of the University of Zurich and as the seat of the "Foundation for Cardiovascular Research", it is one of the most impactful cardiology research and education centres in Europe. Its reach goes far beyond its home and thanks to its close collaboration with the London Heart House involves activities in the United Kingdom, Germany, Easter countries such as Azerbaijan, Georgia, North Macedonia and Mexico.

Thanks to its global reach, the Zurich Heart House is a place of creative knowledge exchange between researchers, scientists, clinicians, practicing physicians, lecturers and staff. As a think tank, it is intended to strengthen Zurich as a location and serve as a service centre for doctors and patients with cardiovascular diseases.

Stay up to date with all our events - subscribe to our Newsletter HERE!


PCHF London Online 3rd Edition - Brand NEW Modules are now available!!!
Check them out here: www.pchfonline.uk

Enjoy discounted pricing with our bundles!

If you would like to purchase a combination of modules that is not available as a bundle, please contact us, and we will be happy to offer you a customized discounted option.

BCS and BSH members get a 10% discount! To get the discount please send us an e-mail at pchfonline@zhh.ch

Do not miss this opportunity: learn from the best, stay up to date with the latest developments in Heart Failure and in your own pace and convenience.

Start learning NOW!


Annual Report 2025*

 

*in German

 

ZHH News

Peri-Echo 2026

Postgraduate Course in Periprocedural Echocardiography 2026 | Replay videos are NOW available on demand!

The video recordings of the  Postgraduate Course in Periprocedural Echocardiography 2026 are now available on demand HERE!

Florian A. Wenzl Award

Dr. Florian A. Wenzl receives 'Breakthrough of the Year' Recognition and Hans and Blanca Moser Research Prize

For his work on applying artificial intelligence (AI) to refine cardiovascular risk prediction, Dr. Florian A. Wenzl recently received the 'Breakthrough of the Year' Recognition....

Learn more here!

CMM 2026

Postgraduate Course in Cardiometabolic Medicine 2026 | Replay videos are NOW available on demand!

The video recordings of the  Postgraduate Course in Cardiometabolic Medicine 2026 are now available on demand HERE!

Cardiology News

Adrenomedullin

Adrenomedullin system dysregulation predicts cardiogenic shock and mortality in acute coronary syndromes

Does the inclusion of markers of the adrenomedullin (ADM) system improve early prediction of cardiogenic shock and mortality
in initially stable patients with acute coronary syndromes (ACS)?

Read the full article (Eur Heart J. 2026;00:1–16) here!

Takotsubo

Takotsubo syndrome diagnosis: the biomarker-based BioTAK score

Currently, takotsubo syndrome (TTS) is diagnosed based on clinical examination, medical, psychiatric, and neurological history, repeated cardiac imaging, and coronary angiography, leading to delayed diagnosis and potentially avoidable invasive procedures. Can biomarkers help the early differentiation of TTS from acute coronary syndrome (ACS)?

Read full article (Eur Heart J. 2026;00:1–14) here!
 

CONSORT diagram

Cliramitug for depletion of cardiac amyloid transthyretin: long-term follow-up of the NI006-101 trial

In a first-in-human trial (NI006-101), the monoclonal antibody cliramitug, targeting misfolded transthyretin, demonstrated a favorable safety profile and time- and dose-dependent reductions in surrogate markers of cardiac amyloid burden over the course of 12 months in patients with amyloid transthyretin cardiomyopathy (ATTR-CM). 

Read full article ( Nat Med 2026 Jun 26) here!